Literature DB >> 23546441

Protective effect of lentivirus-mediated siRNA targeting ADAMTS-5 on cartilage degradation in a rat model of osteoarthritis.

Xiangyu Chu1, Hongbo You, Xuefeng Yuan, Wenbin Zhao, Wenkai Li, Xin Guo.   

Abstract

The etiology of osteoarthritis (OA) is complex and multifaceted. Osteoarthritis is a chronic and progressive disease of the joints that is characterized by the degradation of articular cartilage. A disintegrin and metalloproteinase with thrombospondin motifs-5 (ADAMTS-5) is the major aggrecanase in cartilage. The aim of this study was to evaluate the effect of ADAMTS-5 knockdown on cartilage degradation. Rat articular chondrocytes were transfected with lentivirus‑mediated ADAMTS-5 small interfering RNA (siRNA) or with empty vector control plasmid DNA (as the control). The suppression efficiency was measured using real-time polymerase chain reaction (RT-PCR) and western blot analysis. We then selected the most effective siRNA (siRNA1) and constructed the lentivirus-mediated siRNA targeting ADAMTS-5 for stable transfection. An animal model of OA was created using male Sprague-Dawley rats. OA was induced by performing anterior cruciate ligament transection (ACL-T) and partial medial meniscectomy (PM). The animals (n=80, weight 250‑300 g) received an intra‑articular injection of the empty vector control plasmid DNA or lentivirus‑mediated ADAMTS-5 siRNA1 (20 µl, 1x108 TU/ml). The progression of OA was analyzed using Osteoarthritis Research Society International (OARSI) scores. Compared with the control, ADAMTS-5 gene expression was decreased by approximately 80% by siRNA1 in a monolayer culture of chondrocytes. The intra‑articular injection of lentivirus‑mediated ADAMTS-5 siRNA1 in vivo resulted in the downregulation of ADAMTS-5 protein expression and improved OARSI scores (p<0.05). A single injection of lentivirus‑mediated ADAMTS‑5 siRNA prevented the degradation of articular cartilage. This method may provide a novel therapeutic strategy for the treatment of human OA.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23546441     DOI: 10.3892/ijmm.2013.1318

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  19 in total

Review 1.  Technologies for controlled, local delivery of siRNA.

Authors:  Samantha M Sarett; Christopher E Nelson; Craig L Duvall
Journal:  J Control Release       Date:  2015-11-28       Impact factor: 9.776

2.  BMP-2, hypoxia, and COL1A1/HtrA1 siRNAs favor neo-cartilage hyaline matrix formation in chondrocytes.

Authors:  David Ollitrault; Florence Legendre; Carole Drougard; Mélanie Briand; Hervé Benateau; Didier Goux; Hanane Chajra; Laurent Poulain; Daniel Hartmann; Denis Vivien; Vijayalakshmi Shridhar; Alfonso Baldi; Frédéric Mallein-Gerin; Karim Boumediene; Magali Demoor; Philippe Galera
Journal:  Tissue Eng Part C Methods       Date:  2014-07-31       Impact factor: 3.056

Review 3.  Use of tissue engineering strategies to repair joint tissues in osteoarthritis: viral gene transfer approaches.

Authors:  Magali Cucchiarini; Henning Madry
Journal:  Curr Rheumatol Rep       Date:  2014-10       Impact factor: 4.592

4.  Validation of the Diagnostic and Prognostic Values of ADAMTS5 and FSTL1 in Osteoarthritis Rat Model.

Authors:  Bakheet E M Elsadek; Ahmed A Abdelghany; Mohamed A Abd El-Aziz; Hafez R Madkor; Ahmed Abd Elrady Ahmed; Sary Kh Abd-Elghaffar; Amer Alkot Mostafa Elsadek
Journal:  Cartilage       Date:  2019-06-10       Impact factor: 3.117

5.  The Protective Effect of Evodiamine in Osteoarthritis: An In Vitro and In Vivo Study in Mice Model.

Authors:  Shuyuan Xian; Zeng Lin; Chao Zhou; Xing Wu
Journal:  Front Pharmacol       Date:  2022-06-20       Impact factor: 5.988

Review 6.  ADAMTS-5: A difficult teenager turning 20.

Authors:  Salvatore Santamaria
Journal:  Int J Exp Pathol       Date:  2020-03-27       Impact factor: 1.925

7.  Pterostilbene inhibits inflammation and ROS production in chondrocytes by activating Nrf2 pathway.

Authors:  En-Xing Xue; Jian-Ping Lin; Yu Zhang; Sun-Ren Sheng; Hai-Xiao Liu; Yu-Long Zhou; Hui Xu
Journal:  Oncotarget       Date:  2017-06-27

8.  rAAV-mediated overexpression of TGF-β stably restructures human osteoarthritic articular cartilage in situ.

Authors:  Jagadeesh K Venkatesan; Ana Rey-Rico; Gertrud Schmitt; Anna Wezel; Henning Madry; Magali Cucchiarini
Journal:  J Transl Med       Date:  2013-09-13       Impact factor: 5.531

9.  Construction and verification of the targeted uPA-shRNA lentiviral vector and evaluation of the transfection and silencing rate.

Authors:  Wei-Shan Wang; Feng-Jing Guo; Chang-Jun Li; Zhen-Dong Zhang; Chen-Hui Shi
Journal:  Exp Ther Med       Date:  2014-05-28       Impact factor: 2.447

10.  Identification of differentially expressed microRNAs in knee anterior cruciate ligament tissues surgically removed from patients with osteoarthritis.

Authors:  Bin Li; Lunhao Bai; Peng Shen; Yue Sun; Zhizuo Chen; Yu Wen
Journal:  Int J Mol Med       Date:  2017-07-31       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.